Back
EZCORP, Inc. 10K Form
Buy
66
EZPW
EZCORP, Inc.
Last Price:
$24.32
Seasonality Move:
1.09%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-01 | 10Q | EZPW/EZCORP, Inc. Quarterly |
| 2024-01-31 | 10Q | EZPW/EZCORP, Inc. Quarterly |
| 2023-08-02 | 10Q | EZPW/EZCORP, Inc. Quarterly |
| 2023-05-03 | 10Q | EZPW/EZCORP, Inc. Quarterly |
| 2023-02-01 | 10Q | EZPW/EZCORP, Inc. Quarterly |
| 2022-08-03 | 10Q | EZPW/EZCORP, Inc. Quarterly |
Receive EZPW News And Ratings
See the #1 stock for the next 7 days that we like better than EZPW
EZPW Financial Statistics
Sales & Book Value
| Annual Sales: | $1.3B |
|---|---|
| Cash Flow: | $33.5M |
| Price / Cash Flow: | 16.14 |
| Annual Sales: | $17.35 |
| Price / Book: | 1.4 |
Profitability
| EPS (TTM): | 1.54800 |
|---|---|
| Net Income (TTM): | $122.9M |
| Gross Margin: | $713.5M |
| Return on Equity: | 12.91% |
| Return on Assets: | 6.72% |
EZCORP, Inc. Earnings Forecast
Key EZCORP, Inc. Financial Ratios
-
The Gross Profit Margin over the past 35 years for EZPW is 55.99%.
-
The Selling, General & Administrative Expenses for EZPW have been equal to 6.55% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 21.01% of Operating Income.
-
The Net Earning history of EZPW is 8.60% of Total Revenues.
-
Per Share Earnings over the last 35 years have been positive in 22 years.
EZCORP, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Consumer Finance |
| Sector: | Financials |
| Current Symbol: | EZPW |
| CUSIP: | 302301 |
| Website: | ezcorp.com |
Debt
| Debt-to-Equity Ratio: | 0.72 |
|---|---|
| Current Ratio: | 6.03 |
| Quick Ratio: | 4.62 |
Price-to-Earnings
| Trailing P/E Ratio: | 17.12 |
|---|---|
| Forward P/E Ratio: | 11.98 |
EZPW Technical Analysis vs Fundamental Analysis
Buy
66
EZCORP, Inc. (EZPW)
is a Buy
Is EZCORP, Inc. a Buy or a Sell?
-
EZCORP, Inc. stock is rated a BuyThe current EZCORP, Inc. [EZPW] share price is $24.31. The Score for EZPW is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.